Lexington, Mass. - Voyager Therapeutics, a leading biotechnology company, has announced a collaboration and license agreement with pharmaceutical giant Novartis. This deal, potentially worth over $1 billion, marks an exciting development for both companies. Under the agreement, Voyager will provide Novartis with a target-exclusive license to its Tracer capsids and other … [Read more...] about Voyager Therapeutics Announces Collaboration and License Agreement with Novartis
Footer
